Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment

Quantitative measurement of SARS-CoV-2 neutralizing antibodies is highly expected to evaluate immune status, vaccine response, and antiviral therapy. The Elecsys® Anti-SARS-CoV-2 S (Elecsys® anti-S) was developed to measure anti-SARS-CoV-2 S proteins. We sought to investigate whether Elecsys® anti-S...

Descripción completa

Detalles Bibliográficos
Autores principales: Takei, Satomi, Ai, Tomohiko, Yamamoto, Takamasa, Igawa, Gene, Kanno, Takayuki, Tobiume, Minoru, Hiki, Makoto, Saito, Kaori, Khasawneh, Abdullah, Wakita, Mitsuru, Misawa, Shigeki, Miida, Takashi, Okuzawa, Atsushi, Suzuki, Tadaki, Takahashi, Kazuhisa, Naito, Toshio, Tabe, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477342/
https://www.ncbi.nlm.nih.gov/pubmed/36107911
http://dx.doi.org/10.1371/journal.pone.0274181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477342/
https://www.ncbi.nlm.nih.gov/pubmed/36107911
http://dx.doi.org/10.1371/journal.pone.0274181

Ejemplares similares